Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Olaszország
31 of 39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
- Where
- Busto Arsizio, Cuneo, Ferrara, Monza, Naples, Pavia, Rome, Statte, Telese Terme
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-520473-40-00 - 3. fázisNot yet taking people in OlaszországThe AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
- Where
- Milan, Naples, Roma
- Életkor
- 40 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07907991 · EU 2026-527805-39-00 - 2. fázisNot yet taking people in OlaszországA Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Where
- Bergamo, Ferrara, Florence, Genoa, Milan, Palermo, Rome, Verona
- Életkor
- 40 év to 80 év
- People
- 402 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07725939 · EU 2026-525523-25-00 - No phaseTaking peopleStudy on Impact of Maximal Strength Training in Patients With COPD
- Where
- Lumezzane
- Életkor
- 50 év to 80 év
- People
- 20
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT03799354 - 2. fázisVisszavonvaThe MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
- Where
- Milan
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- University Of Leicester
See details and how to join2025-522359-24-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma, Statte, Telese Terme
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 2/3. fázisNot yet taking people in OlaszországA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Bergamo, Catania, Ferrara, Milan, Naples, Reggio Emilia, Rome
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Cona, Giugliano in Campania, Orbassano, Siena
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Cona, Milan, Padova, Pavia, Reggio Emilia, Rozzano, Telese Terme, Tradate (Va)
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - 4. fázisNot yet taking people in OlaszországThis After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
- Where
- Ferrara, Genoa, Rozzano
- Életkor
- 40 év and over
- People
- 754 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07587658 · EU 2025-524392-23-00 - 2. fázisNot yet taking people in OlaszországA Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
- Where
- Bologna, Ferrara, Milan, Pisa
- Életkor
- 18 év and over
- People
- 183 worldwide
- Run by
- Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Bari, Catania, Ferrara, Foggia, Genoa, Rome, Rozzano, Telese Terme
- Életkor
- 40 év to 80 év
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - 3. fázisFut, nem toborozA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Ancona, Florence, Genoa, Mestre (VE), Milan, Modena, Naples, Pavia, Perugia, Rome, Siena, Varese
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Brescia
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - 3. fázisFut, nem toborozA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Ferrara, Florence, Montebelluna, Naples, Pavia, Rome, Sassari, Telese Terme, Tradate
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00 - 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Brescia, Ferrara, Naples, Rome, Taranto
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - No phaseTaking peopleIdentification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia
- Where
- Milan
- Életkor
- 18 év and over
- People
- 120
- Run by
- Fondazione Don Carlo Gnocchi ETS
See details and how to joinNCT07707245 - No phaseTaking peopleEffect of Combined Endurance Training on ADL and Walking in COPD Patients
- Where
- Lumezzane, Montescano, Tradate
- People
- 36
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT05708443 - No phaseTaking peopleEffect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation
- Where
- Codogno
- Életkor
- 18 év and over
- People
- 23
- Run by
- Azienda Socio Sanitaria Territoriale di Lodi
See details and how to joinNCT07665931 - No phaseTaking peopleEffects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia
- Where
- Bari, Lumezzane, Montescano, Pavia, Taranto, Veruno
- Életkor
- 18 év and over
- People
- 114
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07451977 - No phaseTaking peopleClinical-ultrasonographic Assessment of Pulmonary Emphysema
- Where
- Acquaviva Delle Fonti, Naples, Rome, Trento
- Életkor
- 18 év and over
- People
- 1628
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06533371 - No phaseTaking peopleUltrasound and Respiratory Physiological Signals in Lung Diseases
- Where
- Rome
- Életkor
- 18 év and over
- People
- 25
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06068647 - 4. fázisNot yet taking people in OlaszországEffect of add-on Doxofylline on Lung Function in Stable COPD
- Where
- Milan
- Életkor
- 40 év and over
- People
- 78
- Run by
- University of Milan
See details and how to joinNCT04238221 - 4. fázisTaking peopleImmuno-inflammatory Response of Erdosteine in COPD
- Where
- Milan
- Életkor
- 45 év and over
- People
- 30
- Run by
- Pierachille Santus, MD, PhD
See details and how to joinNCT07329946 · EU 2025-524821-42-00 - No phaseTaking peopleRehabilitation Training With Music-support & Exercise Tolerance in COPD and CRF Patients.
- Where
- Bari, Lumezzane, Montescano, Pavia, Telese Terme, Tradate
- Életkor
- 40 év to 85 év
- People
- 156
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT05720780